David Le Couteur

Professor David Le Couteur is a distinguished academic and clinician in geriatric medicine at the University of Sydney's Concord Clinical School. He holds roles as a Senior Staff Specialist at Concord Hospital and is affiliated with the ANZAC Research Institute and the Centre for Education and Research on Ageing. His research focuses on biogerontology, liver aging, and geriatric pharmacology, with over 450 peer-reviewed publications and significant grant funding ($30M+).

Le Couteur has led editorial roles in top journals like the Journal of Gerontology and served on national committees, including the Pharmaceutical Benefits Advisory Committee. His awards include the AO (2016), FAHMS (2017), and the Ruthven Blackburn Medal (2023). His work spans drug development, aging mechanisms, and translational research, with contributions to dietary interventions and metabolic health in aging populations.

Key areas of research include the impact of macronutrients on aging, liver sinusoidal biology, and the role of pharmacological agents like metformin in longevity. His studies often utilize mouse models and human cohort data, such as the Concord Health and Ageing in Men Project (CHAMP), to explore aging-related comorbidities and interventions.

Le Couteur's articles highlight themes like nutritional geometry, drug evaluation in aging populations, and molecular mechanisms underlying lifespan. His work bridges basic science and clinical practice, emphasizing the importance of interdisciplinary approaches to address aging-related health challenges.

Awards and honors reflect his contributions to pharmacology, geriatric medicine, and health policy. He has been a vocal advocate for deprescribing practices in older adults and has shaped guidelines for medication use in aging populations.